| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chanteloup NK et al. | The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. | 2011 | Vet. Microbiol. | pmid:20708353 |
| Rushing EC et al. | Iatrogenic oral hairy leukoplakia: report of two cases. | 2011 | J. Cutan. Pathol. | pmid:21121942 |
| Berger J et al. | Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. | 2011 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:21123756 |
| Day TP et al. | Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. | 2011 | Mol. Pharm. | pmid:21141891 |
| Kodedová M et al. | Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. | 2011 | BioTechniques | pmid:21231924 |
| Wu D et al. | Traditional Chinese formula, lubricating gut pill, stimulates cAMP-dependent CI(−) secretion across rat distal colonic mucosa. | 2011 | J Ethnopharmacol | pmid:21195154 |
| Stewart AK et al. | Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. | 2011 | Am. J. Physiol., Cell Physiol. | pmid:21209359 |
| Fan SR and Liu XP | In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. | 2011 | Mycoses | pmid:20406393 |
| Aydemir C et al. | Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. | 2011 | Arch. Dis. Child. Fetal Neonatal Ed. | pmid:20659937 |
| Xu L et al. | [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts]. | 2011 | Zhonghua Zhong Liu Za Zhi | pmid:22093622 |
| Daniel SJ et al. | Is ototopical nystatin ototoxic? A chinchilla model. | 2011 | Otolaryngol Head Neck Surg | pmid:21860059 |
| Semis R et al. | Activity of an Intralipid formulation of nystatin in murine systemic candidiasis. | 2011 | Int. J. Antimicrob. Agents | pmid:21839619 |
| Sakeer K et al. | Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. | 2010 Jul-Aug | Pharm Dev Technol | pmid:19772376 |
| Peacock G et al. | Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. | 2010 Jan-Feb | J Am Pharm Assoc (2003) | pmid:20097644 |
| Mete E et al. | Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. | 2010 | Arch. Pharm. (Weinheim) | pmid:20232370 |
| Dalben-Dota KF et al. | Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. | 2010 | J Altern Complement Med | pmid:20192913 |
| Samaranayake YH et al. | The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata. | 2010 | Med. Mycol. | pmid:20092419 |
| MartÃnez-Beneyto Y et al. | Use of antifungal agents for oral candidiasis: results of a national survey. | 2010 | Int J Dent Hyg | pmid:20096082 |
| Semis R et al. | Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds. | 2010 | Mycopathologia | pmid:20069459 |
| Ulrych A et al. | Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides. | 2010 | Eur J Mass Spectrom (Chichester, Eng) | pmid:20065516 |